FDA clears pioglitazone for type-2 diabetes

被引：0
|
作者：
不详
机构：
来源：
DRUG NEWS & PERSPECTIVES | 1999年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [41] Early determinants of type-2 diabetes
    Berends, L. M.
    Ozanne, S. E.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 26 (05) : 569 - 580
  • [42] Obesity and type-2 diabetes in the elderly
    Dewan, S
    Wilding, JPH
    GERONTOLOGY, 2003, 49 (03) : 137 - 145
  • [43] Treatment for Patients with Type-2 Diabetes
    Landgraf, Rueediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald H.
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Wiesner, Tobias
    Siegel, Erhard
    DIABETOLOGIE UND STOFFWECHSEL, 2021, 16 : S168 - S206
  • [44] IRON AND INFLAMMATION IN TYPE-2 DIABETES
    Arredondo, M.
    Andrews, M.
    Soto, N.
    Acevedo, I.
    Candia, V.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 43 - 43
  • [45] FROM OBESITY TO TYPE-2 DIABETES
    SCHEEN, AJ
    ACTA CLINICA BELGICA, 1992, 47 : 30 - 36
  • [46] ISLET AMYLOID AND TYPE-2 DIABETES
    CLARK, A
    DIABETIC MEDICINE, 1989, 6 (07) : 561 - 567
  • [47] PREVALENCE OF TYPE-2 DIABETES IN SWEDEN
    SARTOR, G
    ACTA ENDOCRINOLOGICA, 1984, 105 : 27 - 29
  • [48] Risk for the heart: Type-2 diabetes
    Julius, U
    ERNAHRUNGS-UMSCHAU, 2004, 51 (09): : 5 - 6
  • [49] Caution with Type-2 Diabetes and Statins?
    Krome, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (09) : 508 - 509
  • [50] SULFONYLUREAS AND OR INSULIN IN TYPE-2 DIABETES
    GROOP, L
    WIDEN, E
    FRANSSILAKALLUNKI, A
    EKSTRAND, A
    DIABETES 1988, 1989, 800 : 357 - 363
12345